Immunome
Report: Seattle Life Science Market Vacancy Surges to 17% as Funding Recovery Fails to Spur Demand
Market absorption lags despite venture capital rebound to $998M in 2025, up 90.5 percent from prior year Seattle’s life sciences real estate market...
Seattle Life Sciences Market Faces Rising Vacancies as Developers Pump the Brakes
The sector shows mixed signals with surging venture funding, but climbing vacancy rates and stalled construction projects Seattle’s life sciences real estate market...
Immunome Officially Takes 29,344 SQFT in Bothell
Seattle, WA (June 17, 2024) — Newmark announces a lease signing on behalf of Immunome, a biotechnology company, at the Alloy Innovation Center...
Alloy Properties’ 200,000 SQFT Alloy Innovation Center in Bothell Selected as Immunome’s New Headquarters
Alloy Properties (Alloy), a national life science and innovation real estate platform, is proud to announce that Immunome, Inc. (Nasdaq: IMNM), a biotechnology...
Following Merger with East Coast Firm, Biotech Firm Decides to Locate HQ in Seattle
By The Registry Staff Clay Siegall, the co-founder and former CEO of Bothell-based biotech Seagen, is currently leading a new biotech venture through...
